Prevalence and predictors of complementary and alternative medicine/non-pharmacological interventions use for menopausal symptoms within the UK Collaborative Trial of Ovarian Cancer Screening

References

• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47–53
   PubMed Web of Science ®Google Scholar
• Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 2004;140:184–8
   PubMed Web of Science ®Google Scholar
• Buist DS, Newton KM, Miglioretti DL, et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol 2004;104:1042–50
   PubMed Web of Science ®Google Scholar
• Faber A, Bouvy ML, Loskamp L, et al. Dramatic change in prescribing of hormone replacement therapy in The Netherlands after publication of the Million Women Study: a follow-up study. Br J Clin Pharmacol 2005;60:641–7
   PubMed Web of Science ®Google Scholar
• Gayet-Ageron A, Amamra N, Ringa V, et al. Estimated numbers of postmenopausal women treated by hormone therapy in France. Maturitas 2005;52:296–305
   PubMed Web of Science ®Google Scholar
• Menon U, Burnell M, Sharma A, et al. Decline in use of hormone therapy among postmenopausal women in the United Kingdom. Menopause 2007;14:462–7
   PubMed Web of Science ®Google Scholar
• Complementary, Alternative, or Integrative Health: What’s In a Name? Available at: https://nccih.nih.gov/health/integrative-health. Accessed 26 January 2017
   Google Scholar
• MacLennan AH, Wilson DH, Taylor AW. The escalating cost and prevalence of alternative medicine. Prev Med 2002;35:166–73
   PubMed Web of Science ®Google Scholar
• NICE issues first guideline on menopause to stop women suffering in silence. Available at: https://www.nice.org.uk/news/press-and-media/nice-issues-first-guideline-on-menopause-to-stop-women-suffering-in-silence. Accessed 26 January 2017
   Google Scholar
• Posadzki P, Lee MS, Moon TW, et al. Prevalence of complementary and alternative medicine (CAM) use by menopausal women: a systematic review of surveys. Maturitas 2013;75:34–43
   PubMed Web of Science ®Google Scholar
• Peng W, Adams J, Sibbritt DW, Frawley JE. Critical review of complementary and alternative medicine use in menopause: focus on prevalence, motivation, decision-making, and communication. Menopause 2014;21:536–48
   PubMed Web of Science ®Google Scholar
• Daley A, MacArthur C, McManus R, et al. Factors associated with the use of complementary medicine and non-pharmacological interventions in symptomatic menopausal women. Climacteric 2006;9:336–46
   PubMed Web of Science ®Google Scholar
• Bair YA, Gold EB, Azari RA, et al. Use of conventional and complementary health care during the transition to menopause: longitudinal results from the Study of Women’s Health Across the Nation (SWAN). Menopause 2005;12:31–9
   PubMed Web of Science ®Google Scholar
• Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Practice 2012;66:924–39
   PubMed Web of Science ®Google Scholar
• Menon U, Gentry-Maharaj A, Ryan A, et al. Recruitment to multicentre trials-lessons from UKCTOCS: descriptive study. BMJ (Clin Res Ed) 2008;337:a2079
   PubMed Web of Science ®Google Scholar
• Fraser L, Burnell M, Salter LC, et al. Identifying hopelessness in population research: a validation study of two brief measures of hopelessness. BMJ Open 2014;4:e005093
   PubMed Web of Science ®Google Scholar
• Multivariate probit regression using simulated maximum likelihood. Available at: http://www.stata-journal.com/article.html?article=st0045. Accessed 26 January 2017
   Google Scholar
• Gollschewski S, Anderson D, Skerman H, Lyons-Wall P. Associations between the use of complementary and alternative medications and demographic, health and lifestyle factors in mid-life Australian women. Climacteric 2005;8:271–8
   PubMed Web of Science ®Google Scholar
• Cardini F, Lesi G, Lombardo F, van der Sluijs C. The use of complementary and alternative medicine by women experiencing menopausal symptoms in Bologna. BMC Womens Health 2010;10:7
   PubMed Web of Science ®Google Scholar
• Duffy OK, Iversen L, Hannaford PC. The impact and management of symptoms experienced at midlife: a community-based study of women in northeast Scotland. BJOG 2012;119:554–64
   PubMed Web of Science ®Google Scholar
• Lunny CA, Fraser SN. The use of complementary and alternative medicines among a sample of Canadian menopausal-aged women. J Midwifery Womens Health 2010;55:335–43
   PubMed Web of Science ®Google Scholar
• Bair YA, Gold EB, Greendale GA, et al. Ethnic differences in use of complementary and alternative medicine at midlife: longitudinal results from SWAN participants. Am J Public Health 2002;92:1832–40
   PubMed Web of Science ®Google Scholar
• Newton KM, Buist DS, Keenan NL, et al. Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstet Gynecol 2002;100:18–25
   PubMed Web of Science ®Google Scholar
• Hunter MS, Gentry-Maharaj A, Ryan A, et al. Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10,418 British women aged 54-65. BJOG 2012;119:40–50
   PubMed Web of Science ®Google Scholar
• Daoust JL, Mercer LC, Duncan AM. Prevalence of natural health product use in healthy postmenopausal women. Menopause 2006;13:241–50
   PubMed Web of Science ®Google Scholar
• Bair YA, Gold EB, Zhang G, et al. Use of complementary and alternative medicine during the menopause transition: longitudinal results from the Study of Women’s Health Across the Nation. Menopause 2008;15:32–43
   PubMed Web of Science ®Google Scholar
• Dailey RK, Neale AV, Northrup J, et al. Herbal product use and menopause symptom relief in primary care patients: a MetroNet study. J Womens Health (Larchmt) 2003;12:633–41
   PubMed Web of Science ®Google Scholar
• Haskell SG, Bean-Mayberry B, Gordon K. Discontinuing postmenopausal hormone therapy: an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms?. Menopause 2009;16:494–9
   PubMed Web of Science ®Google Scholar
• Alloy LB, Abramson LY, Metalsky GI, Hartlage S. The hopelessness theory of depression: attributional aspects. Br J Clin Psychol/Br Psychol Soc 1988;27:5–21
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA, Kovacs M, Garrison B. Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry 1985;142:559–63
   PubMed Web of Science ®Google Scholar
• Everson SA, Kaplan GA, Goldberg DE, Salonen JT. Hypertension incidence is predicted by high levels of hopelessness in Finnish men. Hypertension 2000;35:561–7
   PubMed Web of Science ®Google Scholar
• Everson SA, Kaplan GA, Goldberg DE, et al. Hopelessness and 4-year progression of carotid atherosclerosis. The Kuopio Ischemic Heart Disease Risk Factor Study. Arterioscler Thromb Vasc Biol 1997;17:1490–5
   PubMed Web of Science ®Google Scholar
• Whipple MO, Lewis TT, Sutton-Tyrrell K, et al. Hopelessness, depressive symptoms, and carotid atherosclerosis in women: the Study of Women’s Health Across the Nation (SWAN) heart study. Stroke 2009;40:3166–72
   PubMed Web of Science ®Google Scholar
• Dunn SL, Corser W, Stommel M, Holmes-Rovner M. Hopelessness and depression in the early recovery period after hospitalization for acute coronary syndrome. J Cardiopulm Rehabil 2006;26:152–9
   PubMedGoogle Scholar
• Watson M, Homewood J, Haviland J. Coping response and survival in breast cancer patients: a new analysis. Stress Health 2012;28:376–80
   PubMed Web of Science ®Google Scholar
• Molassiotis A, Van Den Akker OB, Milligan DW, Goldman JM. Symptom distress, coping style and biological variables as predictors of survival after bone marrow transplantation. J Psychosom Res 1997;42:275–85
   PubMed Web of Science ®Google Scholar
• Bishop FL, Yardley L, Lewith GT. Why do people use different forms of complementary medicine? Multivariate associations between treatment and illness beliefs and complementary medicine use. Psychol Health 2006;21:683–98
   Web of Science ®Google Scholar
• Söllner W, Maislinger S, DeVries A, et al. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer 2000;89:873–80
   PubMed Web of Science ®Google Scholar
• Gentry-Maharaj A, Karpinskyj C, Glazer C, et al. Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study. Menopause 2015;22:384–90
   PubMed Web of Science ®Google Scholar
• Hamoda H, Panay N, Arya R, Savvas M. The British Menopause Society & Women’s Health Concern 2016 recommendations on hormone replacement therapy in menopausal women. Post Reproductive Health 2016; 22:165–83
   Google Scholar
• Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA 2013;310:1353–68
   PubMed Web of Science ®Google Scholar
• Baber RJ, Panay N, Fenton A. IMS Writing Group. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 2016;19:109–50
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). Menopause: diagnosis and management: NICE Guideline NG23. 2015
   Google Scholar
• Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause 2015;22:1155–72
   PubMed Web of Science ®Google Scholar
• Geller SE, Studee L. Botanical and dietary supplements for menopausal symptoms: what works, what does not. J Womens Health (Larchmt) 2005;14:634–49
   PubMed Web of Science ®Google Scholar
• Posadzki P, Ernst E. Prevalence of CAM use by UK climacteric women: a systematic review of surveys. Climacteric 2013;16:3–7
   PubMed Web of Science ®Google Scholar
• Burnell M, Gentry-Maharaj A, Ryan A, et al. Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials. Trials 2011;12:61
   PubMed Web of Science ®Google Scholar
• Office for National Statistics. Ethnicity and National Identity in England and Wales: 2011. Available at: http://www.ons.gov.uk/peoplepopulationandcommunity/culturalidentity/ethnicity/articles/ethnicityandnationalidentityinenglandandwales/2012-12-11
   Google Scholar